EcoDrugPlus

Ensembl ID : ENSODEG00000012856
Gene Symbol: -
Cross references: -
235 Possible Orthologues:

Ensembl ID : ENSODEG00000011892
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSODEG00000004970
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSODEG00000003864
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSODEG00000018853
Gene Symbol: -
Cross references: -
48 Possible Orthologues:

Ensembl ID : ENSODEG00000012704
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSODEG00000005724
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSODEG00000018632
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSODEG00000001540
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSODEG00000019575
Gene Symbol: -
Cross references: -
156 Possible Orthologues:

Ensembl ID : ENSODEG00000019438
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSODEG00000013233
Gene Symbol: -
Cross references: -
155 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).